Concomitant expression of epidermal growth factor receptor (EGFR) with its ligand, such as EGF, transforming growth factor α (TGFα) or amphiregulin has been associated with decreased patient survival in pancreatic cancer [16]. This evidence concerns the gene EGF and familial pancreatic carcinoma.